Dokter Raf Coremans: what changed
What changed
Dokter Raf Coremans
NACE 86.210, General medical practice
filed annual accounts (NBB)
Net result for the year
€90,515
2024 · €60,397+€30,118
Equity
€210,485
2024 · €119,970+€90,515
Cash
€192,999
2024 · €119,885+€73,115
Balance sheet total
€221,088
2024 · €139,415+€81,674
Largest movements
Assets
- Cash +€73,115
up €73,115 (+61.0%), from €119,885 to €192,999
mainly Net result for the year (+€90,515) and Trade debts (+€1,714)
- Current investments +€11,779
up €11,779 (+200%), from €5,890 to €17,669
Equity and liabilities
- Profit (loss) carried forward +€90,515
up €90,515 (+78.1%), from €115,970 to €206,485
- Tax, wage and social debts -€5,443
down €5,443 (-75.8%), from €7,182 to €1,739
- Other debts -€4,938
down €4,938 (-84.1%), from €5,875 to €936
Income statement
- Gross operating margin +€41,386
up €41,386 (+54.3%), from €76,283 to €117,669
- Taxes +€9,767
up €9,767 (+64.2%), from €15,210 to €24,977
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€60,397
Gross operating margin
+€41,386
Depreciation
-€1,063
Other operating charges
-€562
Financial income
+€661
Financial charges
-€538
Taxes
-€9,767
Result 2025
€90,515
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€84,894
Investment
-€11,779
Financing
€0
Cash 2024
€119,885
From operations (derived)
+€84,894
Net result for the year
+€90,515
Depreciation
+€1,615
Receivables within one year
+€1,305
Deferred charges and accrued income
+€300
Trade debts
+€1,714
Tax, wage and social debts
-€5,443
Other debts
-€4,938
Accrued charges and deferred income
-€175
Investment (derived)
-€11,779
Current investments
-€11,779
Cash 2025
€192,999
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €139,415 | €221,088 | +€81,674 | +58.6% |
| Fixed assets | 21/28 | €4,294 | €2,679 | -€1,615 | -37.6% |
| Tangible fixed assets | 22/27 | €4,294 | €2,679 | -€1,615 | -37.6% |
| Plant, machinery and equipment | 23 | €4,294 | €2,679 | -€1,615 | -37.6% |
| Current assets | 29/58 | €135,121 | €218,410 | +€83,289 | +61.6% |
| Amounts receivable within one year | 40/41 | €3,100 | €1,796 | -€1,305 | -42.1% |
| Trade receivables | 40 | €3,100 | €1,796 | -€1,305 | -42.1% |
| Current investments | 50/53 | €5,890 | €17,669 | +€11,779 | +200% |
| Cash at bank and in hand | 54/58 | €119,885 | €192,999 | +€73,115 | +61.0% |
| Deferred charges and accrued income | 490/1 | €6,246 | €5,946 | -€300 | -4.8% |
| Total equity and liabilities | 10/49 | €139,415 | €221,088 | +€81,674 | +58.6% |
| Equity | 10/15 | €119,970 | €210,485 | +€90,515 | +75.4% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €115,970 | €206,485 | +€90,515 | +78.1% |
| Amounts payable | 17/49 | €19,444 | €10,603 | -€8,841 | -45.5% |
| Amounts payable within one year | 42/48 | €19,266 | €10,600 | -€8,667 | -45.0% |
| Trade debts | 44 | €6,210 | €7,925 | +€1,714 | +27.6% |
| Suppliers | 440/4 | €6,210 | €7,925 | +€1,714 | +27.6% |
| Taxes, remuneration and social security | 45 | €7,182 | €1,739 | -€5,443 | -75.8% |
| Taxes | 450/3 | €7,182 | €1,739 | -€5,443 | -75.8% |
| Other amounts payable | 47/48 | €5,875 | €936 | -€4,938 | -84.1% |
| Accrued charges and deferred income | 492/3 | €178 | €3 | -€175 | -98.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €552 | €1,615 | +€1,063 | +193% |
| Other operating charges | 640/8 | €64 | €625 | +€562 | +880% |
| Gross operating margin | 9900 | €76,283 | €117,669 | +€41,386 | +54.3% |
| Operating profit (loss) | 9901 | €75,667 | €115,428 | +€39,761 | +52.5% |
| Financial income | 75/76B | €94 | €755 | +€661 | +702% |
| Recurring financial income | 75 | €94 | €755 | +€661 | +702% |
| Financial charges | 65/66B | €154 | €692 | +€538 | +349% |
| Recurring financial charges | 65 | €154 | €692 | +€538 | +349% |
| Profit (loss) for the period before taxes | 9903 | €75,607 | €115,492 | +€39,885 | +52.8% |
| Income taxes | 67/77 | €15,210 | €24,977 | +€9,767 | +64.2% |
| Profit (loss) for the period | 9904 | €60,397 | €90,515 | +€30,118 | +49.9% |
| Profit (loss) for the period to be appropriated | 9905 | €60,397 | €90,515 | +€30,118 | +49.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.